Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5427)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,400
Price
$497.54
Total Value
$696.56K
Shares Held After
47,620
% of Holdings
2.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
1,100
Price
$103.20
Total Value
$113.52K
Shares Held After
700
% of Holdings
61.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
2,873
Price
$496.58
Total Value
$1.43M
Shares Held After
49,020
% of Holdings
5.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
3,501
Price
$102.39
Total Value
$358.47K
Shares Held After
1,800
% of Holdings
66.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,579
Price
$495.97
Total Value
$783.13K
Shares Held After
51,893
% of Holdings
3.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
6,771
Price
$101.37
Total Value
$686.38K
Shares Held After
5,301
% of Holdings
56.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
7,928
Price
$100.43
Total Value
$796.21K
Shares Held After
12,072
% of Holdings
39.6%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
376
Price
$68.45
Total Value
$25.74K
Shares Held After
1,296,594
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
9,624
Price
$67.83
Total Value
$652.80K
Shares Held After
1,296,970
% of Holdings
0.7%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
800
Price
$43.00
Total Value
$34.40K
Shares Held After
13,115
% of Holdings
5.7%
TELA Bio, Inc. (TELA)
Capper Joseph H — Director
Shares
25,000
Price
$1.22
Total Value
$30.53K
Shares Held After
179,827
% of Holdings
13.9%
Alignment Healthcare, Inc. (ALHC)
KONOWIECKI JOSEPH S — Director
Shares
23,511
Price
$8.61
Total Value
$202.43K
Shares Held After
1,080,305
% of Holdings
2.1%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
1,921
Price
$4.56
Total Value
$8.76K
Shares Held After
2,803,446
% of Holdings
0.1%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
24,000
Price
$0.21
Total Value
$4.99K
Shares Held After
126,822
% of Holdings
18.9%
ICON PLC (ICLR)
McCague Eugene Pacelli — Director
Shares
3,255
Price
$175.00
Total Value
$569.62K
Shares Held After
3,811
% of Holdings
46.1%
ICON PLC (ICLR)
Murphy Ronan Martin — Director
Shares
5,005
Price
$175.00
Total Value
$875.88K
Shares Held After
3,847
% of Holdings
56.5%
908 Devices Inc. (MASS)
Kenneweg John — SVP, Sales&Product Marketing
Shares
5,257
Price
$10.22
Total Value
$53.73K
Shares Held After
57,784
% of Holdings
8.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
6,802
Price
$64.95
Total Value
$441.80K
Shares Held After
432,886
% of Holdings
1.5%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
101,691
Price
$64.59
Total Value
$6.57M
Shares Held After
439,688
% of Holdings
18.8%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
8,282
Price
$65.07
Total Value
$538.92K
Shares Held After
117,066
% of Holdings
6.6%
Canopy Growth Corp (CGC)
Stewart Thomas Carlton — Chief Financial Officer and Chief Accounting Officer
Shares
25,755
Price
$0.93
Total Value
$23.95K
Shares Held After
588,412
% of Holdings
4.2%
Caris Life Sciences, Inc. (CAI)
Brille Brian J — Director
Shares
400,000
Price
$30.33
Total Value
$12.13M
Shares Held After
230,303
% of Holdings
63.5%
Dogecoin Cash, Inc. (CBDS)
TOBIAS DAVID — Director
Shares
180,000
Price
$0.01
Total Value
$1.80K
Shares Held After
23,615,742
% of Holdings
0.8%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
1,635
Price
$13.65
Total Value
$22.32K
Shares Held After
8,617
% of Holdings
15.9%
Bolt Biotherapeutics, Inc. (BOLT)
Quinn William P. — Director
Shares
1,889
Price
$3.77
Total Value
$7.13K
Shares Held After
41,061
% of Holdings
4.4%
Bolt Biotherapeutics, Inc. (BOLT)
Nemec Sarah — Senior VP, Finance and PAO
Shares
843
Price
$3.77
Total Value
$3.18K
Shares Held After
24,081
% of Holdings
3.4%
Bolt Biotherapeutics, Inc. (BOLT)
Yonehiro Grant — Chief Operating Officer
Shares
1,417
Price
$3.77
Total Value
$5.35K
Shares Held After
29,028
% of Holdings
4.7%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,654
Price
$153.24
Total Value
$253.46K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
989
Price
$152.36
Total Value
$150.69K
Shares Held After
1,654
% of Holdings
37.4%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,659
Price
$151.16
Total Value
$250.77K
Shares Held After
2,643
% of Holdings
38.6%
REVVITY, INC. (RVTY)
Vohra Tajinder S — Senior Vice President, Global Operations
Shares
7,330
Price
$140.88
Total Value
$1.03M
Shares Held After
6,635
% of Holdings
52.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
3,674
Price
$25.00
Total Value
$91.85K
Shares Held After
112,508
% of Holdings
3.2%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
700
Price
$70.00
Total Value
$49.00K
Shares Held After
15,874
% of Holdings
4.2%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
7,869
Price
$28.57
Total Value
$224.82K
Shares Held After
220,867
% of Holdings
3.4%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
107,537
Price
$28.02
Total Value
$3.01M
Shares Held After
228,736
% of Holdings
32.0%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
296
Price
$100.82
Total Value
$29.84K
Shares Held After
3,946
% of Holdings
7.0%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
1,285
Price
$1.91
Total Value
$2.45K
Shares Held After
5,616
% of Holdings
18.6%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
32,607
Price
$1.91
Total Value
$62.28K
Shares Held After
142,463
% of Holdings
18.6%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
1,747
Price
$199.30
Total Value
$348.18K
Shares Held After
42,116
% of Holdings
4.0%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
27
Price
$195.05
Total Value
$5.27K
Shares Held After
43,863
% of Holdings
0.1%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
5,484
Price
$199.30
Total Value
$1.09M
Shares Held After
286,307
% of Holdings
1.9%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
336
Price
$199.30
Total Value
$66.97K
Shares Held After
52,868
% of Holdings
0.6%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
85
Price
$195.01
Total Value
$16.58K
Shares Held After
291,791
% of Holdings
0.0%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
5
Price
$194.96
Total Value
$974.79
Shares Held After
53,204
% of Holdings
0.0%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
4,891
Price
$199.30
Total Value
$974.79K
Shares Held After
149,680
% of Holdings
3.2%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
76
Price
$195.01
Total Value
$14.82K
Shares Held After
154,571
% of Holdings
0.0%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — SVP&General Counsel
Shares
3,314
Price
$199.30
Total Value
$660.49K
Shares Held After
52,541
% of Holdings
5.9%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — SVP&General Counsel
Shares
52
Price
$195.01
Total Value
$10.14K
Shares Held After
55,855
% of Holdings
0.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
13,775
Price
$199.30
Total Value
$2.75M
Shares Held After
253,342
% of Holdings
5.2%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
3,992
Price
$199.30
Total Value
$795.62K
Shares Held After
119,216
% of Holdings
3.2%
Showing 301–350 of 5427 transactions (page 7 of 109)